Renaissance Technologies’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.13M Sell
803,283
-39,800
-5% -$431K 0.01% 1013
2025
Q4
$10.8M Sell
843,083
-90,300
-10% -$1.11M 0.02% 879
2025
Q3
$10.4M Sell
933,383
-129,346
-12% -$1.25M 0.01% 1080
2025
Q2
$10.5M Buy
1,062,729
+166,800
+19% +$1.63M 0.01% 1031
2025
Q1
$8.41M Sell
895,929
-17,100
-2% -$180K 0.01% 1102
2024
Q4
$8.36M Sell
913,029
-143,785
-14% -$1.06M 0.01% 1127
2024
Q3
$8.22M Sell
1,056,814
-40,800
-4% -$295K 0.01% 1143
2024
Q2
$6.64M Sell
1,097,614
-40,900
-4% -$252K 0.01% 1134
2024
Q1
$6.68M Buy
1,138,514
+274,431
+32% +$1.63M 0.01% 1229
2023
Q4
$6.77M Buy
864,083
+205,769
+31% +$1.43M 0.01% 1159
2023
Q3
$4.81M Buy
658,314
+156,600
+31% +$1.3M 0.01% 1333
2023
Q2
$5.23M Buy
501,714
+119,900
+31% +$1.15M 0.01% 1411
2023
Q1
$3.95M Sell
381,814
-78,000
-17% -$998K 0.01% 1616
2022
Q4
$6.33M Buy
459,814
+6,800
+2% +$94.6K 0.01% 1364
2022
Q3
$9.27M Sell
453,014
-43,100
-9% -$946K 0.01% 1076
2022
Q2
$9.6M Buy
496,114
+27,500
+6% +$563K 0.01% 1135
2022
Q1
$10.1M Sell
468,614
-64,500
-12% -$1.46M 0.01% 1120
2021
Q4
$14.7M Sell
533,114
-40,800
-7% -$1.13M 0.02% 872
2021
Q3
$14.9M Buy
573,914
+71,146
+14% +$1.9M 0.02% 819
2021
Q2
$13.6M Sell
502,768
-48,600
-9% -$1.19M 0.02% 971
2021
Q1
$12.9M Sell
551,368
-207,546
-27% -$4.19M 0.02% 1030
2020
Q4
$11.6M Sell
758,914
-225,700
-23% -$2.86M 0.01% 1064
2020
Q3
$11.9M Buy
984,614
+157,933
+19% +$1.5M 0.01% 1027
2020
Q2
$8.41M Sell
826,681
-73,633
-8% -$759K 0.01% 1328
2020
Q1
$9.39M Buy
900,314
+245,100
+37% +$3.08M 0.01% 1204
2019
Q4
$10.5M Buy
655,214
+149,268
+30% +$2.28M 0.01% 1415
2019
Q3
$9.32M Buy
505,946
+124,600
+33% +$2.44M 0.01% 1433
2019
Q2
$7.51M Sell
381,346
-114,600
-23% -$2.33M 0.01% 1585
2019
Q1
$11.3M Sell
495,946
-84,954
-15% -$1.84M 0.01% 1302
2018
Q4
$11.7M Sell
580,900
-25,500
-4% -$528K 0.01% 1210
2018
Q3
$13.2M Sell
606,400
-41,200
-6% -$915K 0.01% 1176
2018
Q2
$14.4M Buy
647,600
+6,500
+1% +$133K 0.02% 1136
2018
Q1
$11.1M Buy
641,100
+99,300
+18% +$1.66M 0.01% 1298
2017
Q4
$9.01M Buy
541,800
+82,300
+18% +$1.4M 0.01% 1449
2017
Q3
$7.85M Sell
459,500
-214,210
-32% -$3.6M 0.01% 1470
2017
Q2
$10.9M Buy
673,710
+167,510
+33% +$2.65M 0.01% 1231
2017
Q1
$8.78M Sell
506,200
-102,446
-17% -$1.71M 0.01% 1326
2016
Q4
$10.3M Sell
608,646
-17,200
-3% -$287K 0.02% 1203
2016
Q3
$11M Buy
625,846
+131,446
+27% +$2.13M 0.02% 1092
2016
Q2
$7.11M Buy
494,400
+55,900
+13% +$699K 0.01% 1373
2016
Q1
$5.39M Buy
438,500
+74,100
+20% +$819K 0.01% 1568
2015
Q4
$4.42M Buy
364,400
+107,549
+42% +$1.32M 0.01% 1571
2015
Q3
$3.39M Buy
256,851
+40,251
+19% +$608K 0.01% 1653
2015
Q2
$3.55M Sell
216,600
-47,246
-18% -$784K 0.01% 1668
2015
Q1
$4.69M Sell
263,846
-107,700
-29% -$2M 0.01% 1408
2014
Q4
$7.06M Buy
371,546
+218,386
+143% +$3.7M 0.02% 1074
2014
Q3
$2.1M Buy
153,160
+61,160
+66% +$873K 0.01% 1650
2014
Q2
$1.5M Buy
92,000
+24,454
+36% +$354K ﹤0.01% 1873
2014
Q1
$1.06M Sell
67,546
-118,500
-64% -$1.93M ﹤0.01% 2051
2013
Q4
$3.19M Buy
186,046
+93,323
+101% +$1.44M 0.01% 1467
2013
Q3
$1.22M Buy
92,723
+74,777
+417% +$882K ﹤0.01% 1913
2013
Q2
$202K Buy
+17,946
New +$191K ﹤0.01% 2517

Other funds holding ANGO

Renaissance Technologies's ANGO Position: Q1 2026 in Review

Renaissance Technologies reduced its AngioDynamics (ANGO) stake by 4.7% in Q1 2026, selling an estimated $431K and leaving 803,283 shares worth $9.13M. The position accounts for 0.01% of the portfolio, ranked #1013.

Renaissance Technologies first reported a position in ANGO in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.9M in Q3 2021. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Renaissance Technologies held 803,283 shares of AngioDynamics worth $9.13M as of Q1 2026.
  • Renaissance Technologies sold 39,800 AngioDynamics shares in Q1 2026, an estimated $431K.
  • AngioDynamics made up 0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1013 holding.
  • Renaissance Technologies first reported a position in AngioDynamics in Q2 2013 and has held it in 52 quarters since.
  • Renaissance Technologies's AngioDynamics position peaked at $14.9M in Q3 2021.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.